Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
      • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/2
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
May 02, 2025May 06, 2025Akkaraju Srinivas
Dir
BuyAlumis Inc.ALMS$4.61$1M+8.20%
Mar 13, 2025Mar 18, 2025Akkaraju Srinivas
Dir
BuyMineralys Therapeutics, Inc.MLYS$13.5$8M+9.56%
Oct 07, 2024Oct 08, 2024Akkaraju Srinivas
Dir
SellScholar Rock Holding CorpSRRK$29.25$34M-8.99%
Jul 01, 2024Aug 27, 2024Akkaraju Srinivas
Dir
BuyAlumis Inc.ALMS$16$25M+32.36%
Dec 21, 2023Dec 26, 2023Akkaraju Srinivas
Dir
BuySyros Pharmaceuticals, Inc.SYRS$4.42$4M+33.59%
Oct 16, 2023Oct 18, 2023Akkaraju Srinivas
Dir
10%
BuyScholar Rock Holding CorpSRRK$6.85$15M+24.39%
Feb 14, 2023Feb 16, 2023Akkaraju Srinivas
Dir
10%
BuyMineralys Therapeutics, Inc.MLYS$16$15M+17.18%
May 27, 2022Jun 01, 2022Akkaraju Srinivas
Dir
BuyChinook Therapeutics, Inc.KDNY$14$8M+9.94%
Nov 15, 2021Nov 17, 2021Akkaraju Srinivas
Dir
BuyChinook Therapeutics, Inc.KDNY$14$17M+20.92%
Aug 18, 2021Aug 20, 2021Akkaraju Srinivas
Dir
BuyChinook Therapeutics, Inc.KDNY$11.98$2M+5.82%
Mar 10, 2021Mar 13, 2021Akkaraju Srinivas
Dir
BuyIntercept Pharmaceuticals, Inc.ICPT$21.17$5M+26.31%
Aug 17, 2020Aug 19, 2020Akkaraju Srinivas
Dir
SellSyros Pharmaceuticals, Inc.SYRS$13.1$2M-11.11%
Jul 01, 2020Jul 06, 2020Akkaraju Srinivas
Dir
SellSyros Pharmaceuticals, Inc.SYRS$11.01$50,966-0.32%
Jun 23, 2020Jun 26, 2020Akkaraju Srinivas
Dir
SellSyros Pharmaceuticals, Inc.SYRS$11.11$2M-9.71%
May 05, 2020May 07, 2020Akkaraju Srinivas
Dir
SellSeattle Genetics Inc /waSGEN$167.26$1M-17.47%
Dec 02, 2019Dec 02, 2019Akkaraju Srinivas
Dir
BuyAravive, Inc.ARAV$7.5$999,998+17.99%
Nov 21, 2019Nov 22, 2019Akkaraju Srinivas
Dir
SellSeattle Genetics Inc /waSGEN$119.78$2M-30.35%
Aug 28, 2019Aug 30, 2019Akkaraju Srinivas
Dir
BuyIntercept Pharmaceuticals, Inc.ICPT$60.32$314,086+1.21%
Aug 20, 2019Aug 24, 2019Akkaraju Srinivas
Dir
BuyIntercept Pharmaceuticals, Inc.ICPT$66.37$4M+13.90%
Apr 09, 2019Apr 11, 2019Akkaraju Srinivas
Dir
BuySyros Pharmaceuticals, Inc.SYRS$7.5$4M+25.08%
Feb 19, 2019Feb 22, 2019Akkaraju Srinivas
Dir
SellIntercept Pharmaceuticals, Inc.ICPT$128.78$3M-10.00%
Sep 18, 2018Sep 20, 2018Akkaraju Srinivas
Dir
BuyPrincipia Biopharma Inc.PRNB$17$3M+31.34%
Jun 13, 2018Jun 16, 2018Akkaraju Srinivas
Dir
BuyVersartis, Inc.VSAR$2.13$112,928+1.94%
Jun 06, 2018Jun 08, 2018Akkaraju Srinivas
Dir
BuyVersartis, Inc.VSAR$1.81$2M+28.64%
Jan 31, 2018Feb 02, 2018Akkaraju Srinivas
Dir
BuySyros Pharmaceuticals, Inc.SYRS$9.55$2M+16.50%
Dec 12, 2017Dec 15, 2017Akkaraju Srinivas
Dir
BuySyros Pharmaceuticals, Inc.SYRS$9.03$991,558+11.67%
Dec 01, 2017Dec 06, 2017Akkaraju Srinivas
Dir
BuyVersartis, Inc.VSAR$2.17$2M+38.45%
Mar 24, 2017Mar 29, 2017Akkaraju Srinivas
Dir
BuyVersartis, Inc.VSAR$12.25$7M+49.50%
Oct 03, 2016Oct 04, 2016Akkaraju Srinivas
Dir
BuyVersartis, Inc.VSAR$12.25$7M+49.50%
May 12, 2015May 15, 2015Akkaraju Srinivas
Former 10% Owner
BuyAtyr Pharma IncLIFE$14$4M+14.64%